Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Adverse Reactions Associated with Biologics for Moderate-to-Severe Plaque Psoriasis
In July, our table of the month sums up biologics approved for moderate-to-severe plaque psoriasis and common adverse events associated with these biologics.
Links to PDF
Related Videos
Related Content
